Find Research Outputs

Search in all content

Filters for Research Output

Search concepts
Selected Filters

Publication Year

  • 2020
  • 2019
  • 2017
  • 2016

Author

  • Richard F Ambinder
2020

A tale of two urines

Gupta, A. & Ambinder, R. F., May 1 2020, In : JCO Oncology Practice. 16, 5, 1 p.

Research output: Contribution to journalComment/debate

CpG methylation in cell-free Epstein-Barr virus DNA in patients with EBV-hodgkin lymphoma

Shamay, M., Kanakry, J. A., Low, J. S. W., Horowitz, N. A., Journo, G., Ahuja, A., Eran, Y., Barzilai, E., Dann, E. J., Stone, J., Woo, W. L., Hsieh, W. S., Xian, R. R. & Ambinder, R. F., Apr 28 2020, In : Blood Advances. 4, 8, p. 1624-1627 4 p.

Research output: Contribution to journalArticle

Open Access

Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide

DeZern, A. E., Zahurak, M. L., Symons, H. J., Cooke, K. R., Rosner, G. L., Gladstone, D. E., Huff, C. A., Swinnen, L. J., Imus, P., Borrello, I., Wagner-Johnston, N., Ambinder, R. F., Luznik, L., Bolaños-Meade, J., Fuchs, E. J., Jones, R. J. & Brodsky, R. A., Apr 28 2020, In : Blood Advances. 4, 8, p. 1770-1779 10 p.

Research output: Contribution to journalArticle

Open Access

Kaposi’s sarcoma-associated herpesvirus LANA modulates the stability of the E3 ubiquitin ligase RLIM

Tadmor, H., Greenway, M., Ahuja, A., Orgil, O., Liao, G., Ambinder, R. F., Hayward, S. D. & Shamay, M., Mar 1 2020, In : Journal of virology. 94, 5, e01578-19.

Research output: Contribution to journalArticle

Pilot trial AMC-063: Safety and Efficacy of Bortezomib in AIDS-associated Kaposi Sarcoma

on behalf of the AIDS Malignancy Consortium (AMC), Feb 1 2020, In : Clinical Cancer Research. 26, 3, p. 558-565 8 p.

Research output: Contribution to journalArticle

Single-cell transcriptional landscapes reveal HIV-1-driven aberrant host gene transcription as a potential therapeutic target

Liu, R., Yeh, Y. H. J., Varabyou, A., Collora, J. A., Sherrill-Mix, S., Conover Talbot, C., Mehta, S., Albrecht, K., Hao, H., Zhang, H., Pollack, R. A., Beg, S. A., Calvi, R. M., Hu, J., Durand, C. M., Ambinder, R. F., Hoh, R., Deeks, S. G., Chiarella, J., Spudich, S. & 4 others, Douek, D. C., Bushman, F. D., Pertea, M. & Ho, Y. C., May 13 2020, In : Science translational medicine. 12, 543, eaaz0802.

Research output: Contribution to journalArticle

Open Access
2019

AIDS-related Kaposi sarcoma, version 2.2019

Reid, E., Suneja, G., Ambinder, R. F., Ard, K., Baiocchi, R., Barta, S. K., Carchman, E., Cohen, A., Crysler, O. V., Gupta, N., Gustafson, C., Hall, A., Johung, K. L., Klopp, A., LaCasce, A. S., Lin, C., Mehta, A., Menon, M. P., Morgan, D., Nathwani, N. & 11 others, Noy, A., Ratner, L., Rizza, S., Rudek, M. A., Sanchez, J., Taylor, J., Tomlinson, B., Wang, C. C. J., Yendamuri, S., Dwyer, M. A. & Freedman-Cass, D. A., Feb 2019, In : JNCCN Journal of the National Comprehensive Cancer Network. 17, 2, p. 171-189 19 p.

Research output: Contribution to journalArticle

Allogeneic Hematopoietic Cell Transplant for HIV Patients with Hematologic Malignancies: the BMT CTN-0903/AMC-080 Trial

Ambinder, R. F., Wu, J., Logan, B., Durand, C., Shields, R., Popat, U. R., Little, R. F., McMahon, D. K., Cyktor, J., Mellors, J. W., Ayala, E., Kaplan, L. D., Noy, A., Jones, R. J., Howard, A., Forman, S. J., Porter, D., Arce-Lara, C., Shaughnessy, P., Sproat, L. & 5 others, Hashmi, S. K., Mendizabal, A. M., Horowitz, M. M., Navarro, W. H. & Alvarnas, J. C., Jan 1 2019, In : Biology of Blood and Marrow Transplantation.

Research output: Contribution to journalArticle

Open Access
Open Access

Pharmacologic activation of Lytic Epstein-Barr Virus gene expression without virion production

Lee, J., Kosowicz, J. G., Hayward, S. D., Desai, P., Stone, J., Lee, J. M., Liu, J. O. & Ambinder, R. F., Oct 1 2019, In : Journal of virology. 93, 20, e00998-19.

Research output: Contribution to journalArticle

T-cell receptor sequencing demonstrates persistence of virus-specific T cells after antiviral immunotherapy

Keller, M. D., Darko, S., Lang, H., Ransier, A., Lazarski, C. A., Wang, Y., Hanley, P. J., Davila, B. J., Heimall, J. R., Ambinder, R. F., Barrett, A. J., Rooney, C. M., Heslop, H. E., Douek, D. C. & Bollard, C. M., Jan 1 2019, In : British journal of haematology.

Research output: Contribution to journalArticle

Cancer: Seeing the ebb of a tumour virus

Kosowicz, J. G., Lee, J. & Ambinder, R. F., Apr 10 2017, In : Nature Biomedical Engineering. 1, 4, 0059.

Research output: Contribution to journalComment/debate

Drug modulators of B cell signaling pathways and Epstein-Barr virus lytic activation

Kosowicz, J. G., Lee, J., Peiffer, B., Guo, Z., Chen, J., Liao, G., Diane Hayward, S., Liu, J. & Ambinder, R. F., Aug 1 2017, In : Journal of Virology. 91, 16, e00747-17.

Research output: Contribution to journalArticle

Elevated serum levels of sCD30 and IL6 and detectable il10 precede classical hodgkin lymphoma diagnosis

Levin, L. I., Breen, E. C., Birmann, B. M., Batista, J. L., Magpantay, L. I., Li, Y., Ambinder, R. F., Mueller, N. E. & Martínez-Maza, O., Jul 1 2017, In : Cancer Epidemiology Biomarkers and Prevention. 26, 7, p. 1114-1123 10 p.

Research output: Contribution to journalArticle

Epstein-Barr virus DNA in serum as an early prognostic marker in children and adolescents with Hodgkin lymphoma

Welch, J. J. G., Schwartz, C. L., Higman, M., Chen, L., Buxton, A., Kanakry, J. A., Kahwash, S. B., Hutchison, R. E., Friedman, D. L. & Ambinder, R. F., Apr 25 2017, In : Blood Advances. 1, 11, p. 681-684 4 p.

Research output: Contribution to journalArticle

High frequency of identical clonal immunoglobulin DNA in pre-treatment tumor and plasma from untreated patients with HIV-associated lymphoma: prospective multicenter trial of the AIDS malignancies consortium (AMC 064)

Wagner-Johnston, N., Lensing, S., Noy, A., Ratner, L., Henry, D., Lee, J. Y., Silver, S., Faham, M. & Ambinder, R. F., May 15 2017, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-4 4 p.

Research output: Contribution to journalArticle

Hodgkin lymphoma version 1.2017

Hoppe, R. T., Advani, R. H., Ai, W. Z., Ambinder, R. F., Aoun, P., Bello, C. M., Benitez, C. M., Bernat, K., Bierman, P. J., Blum, K. A., Chen, R., Dabaja, B., Forero, A., Gordon, L. I., Hernandez-Ilizaliturri, F. J., Hochberg, E. P., Huang, J., Johnston, P. B., Kaminski, M. S., Kenkre, V. P. & 17 others, Khan, N., Maloney, D. G., Mauch, P. M., Metzger, M., Moore, J. O., Morgan, D., Moskowitz, C. H., Mulroney, C., Poppe, M., Rabinovitch, R., Seropian, S., Smith, M., Winter, J. N., Yahalom, J., Burns, J., Ogba, N. & Sundar, H., May 1 2017, In : JNCCN Journal of the National Comprehensive Cancer Network. 15, 5, p. 608-638 31 p.

Research output: Contribution to journalReview article

Low immunosuppressive burden after HLA-matched related or unrelated BMT using posttransplantation cyclophosphamide

Kanakry, C. G., Bolanos Meade, F. J., Kasamon, Y. L., Zahurak, M., Durakovic, N., Furlong, T., Mielcarek, M., Medeot, M., Gojo, I., Smith, B. D., Kanakry, J. A., Borrello, I. M., Brodsky, R. A., Gladstone, D., Huff, C. A., Matsui, W. H., Swinnen, L., Cooke, K. R., Ambinder, R. F., Fuchs, E. J. & 6 others, De Lima, M. J., Andersson, B. S., Varadhan, R., O'Donnell, P. V., Jones, R. J. & Luznik, L., Mar 9 2017, In : Blood. 129, 10, p. 1389-1393 5 p.

Research output: Contribution to journalArticle

Pharmacokinetically-targeted dosed everolimus maintenance therapy in lymphoma patients

Schoch, L. K., Asiama, A., Zahurak, M., Shanbhag, S. P., Hurtt, J., Sawyer, K., Swinnen, L., Wagner-Johnston, N., Jones, R. J., Ambinder, R. F. & Gladstone, D., Dec 13 2017, (Accepted/In press) In : Cancer Chemotherapy and Pharmacology. p. 1-8 8 p.

Research output: Contribution to journalArticle

Plasma Epstein–Barr virus DNA for screening

Ambinder, R. F., Aug 10 2017, In : New England Journal of Medicine. 377, 6, p. 584-585 2 p.

Research output: Contribution to journalEditorial

Open Access

Rapamycin-mediated mTOR inhibition uncouples HIV-1 latency reversal from cytokine-associated toxicity

Martin, A. R., Pollack, R. A., Capoferri, A., Ambinder, R. F., Durand, C. & Siliciano, R. F., Feb 1 2017, In : Journal of Clinical Investigation. 127, 2, p. 651-656 6 p.

Research output: Contribution to journalArticle

Th17 immune microenvironment in Epstein-Barr virus-negative Hodgkin lymphoma: Implications for immunotherapy

Duffield, A. S., Ascierto, M. L., Anders, R. A., Taube, J. M., Meeker, A. K., Chen, S., McMiller, T. L., Phillips, N. A., Xu, H., Ogurtsova, A., Berger, A. E., Pardoll, D. M., Topalian, S. L. & Ambinder, R. F., Jul 25 2017, In : Blood Advances. 1, 17, p. 1324-1334 11 p.

Research output: Contribution to journalArticle

Open Access

Treatment of HIV-Associated Lymphomas: The Latest Approaches for Optimizing Outcomes

Hunter, N. B., Vogt, S. & Ambinder, R. F., Dec 15 2017, In : Oncology (Williston Park, N.Y.). 31, 12

Research output: Contribution to journalReview article

Unveiling Kaposi sarcoma viral antigens

Lee, J., Kosowicz, J. G. & Ambinder, R. F., Feb 7 2017, In : Oncotarget. 8, 31, p. 50325-50326 2 p.

Research output: Contribution to journalComment/debate

2016

Allogeneic stem cell transplantation

Ambinder, R. F., Kanakry, J. A. & Durand, C., Jan 1 2016, HIV-Associated Hematological Malignancies. Springer International Publishing, p. 165-171 7 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

A phase 1b/pharmacokinetic trial of PTC299, a novel posttranscriptional VEGF inhibitor, for AIDS-related Kaposi's Sarcoma: AIDS malignancy consortium trial 059

for the AIDS Malignancy Consortium (AMC)-059 Study Team, May 1 2016, In : Journal of acquired immune deficiency syndromes. 72, 1, p. 52-57 6 p.

Research output: Contribution to journalArticle

Autologous hematopoietic cell transplantation for HIV-related lymphoma: Results of the BMT CTN 0803/AMC 071 trial

Alvarnas, J. C., Le Rademacher, J., Wang, Y., Little, R. F., Akpek, G., Ayala, E., Devine, S., Baiocchi, R., Lozanski, G., Kaplan, L., Noy, A., Popat, U., Hsu, J., Morris, L. E., Thompson, J., Horowitz, M. M., Mendizabal, A., Levine, A., Krishnan, A., Forman, S. J. & 2 others, Navarro, W. H. & Ambinder, R., Aug 25 2016, In : Blood. 128, 8, p. 1050-1058 9 p.

Research output: Contribution to journalArticle

Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma

Ratner, L., Rauch, D., Abel, H., Caruso, B., Noy, A., Barta, S. K., Parekh, S., Ramos, J. C., Ambinder, R., Phillips, A., Harding, J., Baydoun, H. H., Cheng, X. & Jacobson, S., Mar 25 2016, In : Blood Cancer Journal. 6, p. e408

Research output: Contribution to journalLetter

EBV, an inhibited receptor kinase, and lymphoma

Ambinder, R. F., Sep 22 2016, In : Blood. 128, 12, p. 1542-1543 2 p.

Research output: Contribution to journalComment/debate

Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers

Li, L., Li, C., Mao, H., Du, Z., Chan, W. Y., Murray, P., Luo, B., Chan, A. T. C., Mok, T. S. K., Chan, F. K. L., Ambinder, R. F. & Tao, Q., May 26 2016, In : Scientific Reports. 6, 26591.

Research output: Contribution to journalArticle

Epstein-Barr Virus Infection

Kanakry, J. A. & Ambinder, R. F., Jan 1 2016, Thomas' Hematopoietic Cell Transplantation: Fifth Edition. Wiley Blackwell, Vol. 2-2. p. 1105-1113 9 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Initial Experience with Tositumomab and I-131-Labeled Tositumomab for Treatment of Relapsed/Refractory Hodgkin Lymphoma

Jacene, H., Crandall, J., Kasamon, Y. L., Ambinder, R. F., Piantadosi, S., Serena, D., Kasecamp, W. & Wahl, R. L., Oct 31 2016, (Accepted/In press) In : Molecular Imaging and Biology. p. 1-8 8 p.

Research output: Contribution to journalArticle

Outcomes in Transplant Recipients Treated with Foscarnet for Ganciclovir-Resistant or Refractory Cytomegalovirus Infection

Avery, R., Boger, R., Marr, K., Kraus, E., Shoham, S., Lees, L., Trollinger, B., Shah, P. D., Ambinder, R. F., Neofytos, D., Ostrander, D. B., Forman, M. & Valsamakis, A., Aug 5 2016, (Accepted/In press) In : Transplantation.

Research output: Contribution to journalArticle

Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium

Noy, A., Lensing, S. Y., Moore, P. C., Gupta, N., Aboulafia, D., Ambinder, R., Baiocchi, R., Dezube, B. J., Henry, D., Kaplan, L., Levine, A. M., Mitsuyasu, R., Ratner, L., Reid, E., Remick, S., Sparano, J., Tzachanis, D., Wachsman, W. & Chadburn, A., Jul 2 2016, In : Leukemia and Lymphoma. 57, 7, p. 1731-1734 4 p.

Research output: Contribution to journalLetter